« Back
COVID-19 Drug Repurposing
Poster Title: COVID-19 Drug Repurposing
Submitted on 02 Jul 2021
Author(s): Lisa George
Poster Views: 176
View poster »

Poster Information
Abstract: Ways to Achieve (a)
Ligand preparation
Select antiviral drugs among contemporary drugs for molecular docking research, so as to screen and confirm effective antiviral drugs specifically for COVID-19. PubChem database can be used to extract the chemical structure of 3D molecules.
Preparation of protein structure
The current COVID-19 main protease has a co-crystal structure. Use the protein preparation wizard in the Maestro panel to prepare the protein structure.
Molecular docking
Molecular docking is a structure-based drug design method that is used to identify the essential amino acid interactions between the selected protein and the generated ligand with a low energy conformation. The docking ligand can be visualized through Maestro interface.
Summary: The method of drug reuse is based on the network. This method uses and integrates the clinical data of COVID-19, and associates protein structure with drug-targeted gene information, so as to find reusable drugs that can treat COVID-19.References: Yonghyun Nam, et al. Network reinforcement driven drug repurposing for COVID-19 by exploiting disease-gene-drug associations. arXiv. 2020.

BhumiShah, et al. In silico studies on therapeutic agents for COVID-19: Drug repurposing approach. Life Science 252(2020), 117652.
Report abuse »
Ask the author a question about this poster.
Ask a Question »

Creative Commons

Related Posters

Immunity Buster Herbal Plant: During Covid-19 Pandemic
Saurav Suryavanshi

QM/MM Simulation
Lisa George

CYTOCON as a tool to collect, compare and visualize available data on cells and cytokine concentrations in humans
Vlad Leonov, Ekaterina Mogilevskaia, Elita Gerasimuk, Nail Gizzatkulov, Oleg Demin

ECD Simulation Prediction
Lisa George

Unified approach for in vitro data based parameters estimation
Veronika Musatova, Oleg Demin, Svetlana Rubina